Non-Diabetes Specialists Drive New Growth in GLP-1 Prescriptions Patients with Type 2 diabetes (T2D) and obesity often present with multiple comorbidities spanning a wide range of diseases, requiring care from diverse specialists
The Titration Process Regardless of which medication you and your healthcare provider choose, you will likely start on a low dose
Once reconstituted, store the vial upright in the refrigerator and draw your weekly dose at your scheduled injection time
Severe gastrointestinal symptoms like persistent nausea, vomiting, or abdominal pain
The findings of this meta-analysis suggest that GLP-1 receptor agonists are not associated with an increased risk of gastrointestinal cancers and were not associated with increased gastrointestinal cancer risk and demonstrated pooled estimates below unity for colorectal and liver cancers, findings that should be interpreted as hypothesis-generating rather than confirmatory of cancer prevention ( Notably, our subgroup analysis showed greater protective effects in older adults and obese individuals, two populations already at heightened risk for gastrointestinal cancers
.png)
